Global use of prescription systemic treatments for eczema 2019
A survey from 2019 of persons with eczema, caregivers of persons with eczema, and spouse, partner, or family members of persons with eczema found that dupilumab was the most commonly used type of prescription systemic treatment among those with eczema. This statistic shows the percentage of patients with eczema worldwide who had used select prescription systemic treatments as of 2019.
